SCIREX Offers Student Scholarships for Attending Medical Communications Conference in Austin

Share Article

SCIREX Corporation announced today their contribution of five scholarships to students attending the American Medical Writing Association’s Southwest Medical Communications Conference in Austin, Texas. Each student scholarship will cover conference registration, enrollment in a workshop, and a small travel stipend.

SCIREX Corporation announced today their contribution of five scholarships to students attending the American Medical Writing Association’s Southwest Medical Communications Conference in Austin, Texas. Each student scholarship will cover conference registration, enrollment in a workshop, and a small travel stipend. The scholarships are awarded on a first-come, first-served basis to conference registrants who are enrolled in health sciences, writing, or journalism programs at institutions outside the greater Austin area in the AMWA Southwest region. This Friday at the conference, the recipients will receive their checks as well as certificates.

High quality Medical Writing is integral to the clinical trial process. Clearly written Investigator brochures and protocols facilitate the conduct of the study, and high quality clinical study reports put the study results into context for clinicians, scientists and regulators. Offering financial assistance to students is a great way to support future medical writers.

"SCIREX is pleased to be able to offer support for students attending the AMWA conference in Austin," said Mary Jane Lunsford, Head of SCIREX’s Medical Writing Department. “It is imperative that we invest in the future of these highly valuable assets.”

To learn more about the American Medical Writer’s Association, please visit http://www.amwa.org.

About SCIREX

SCIREX Corporation (http://www.scirex.com) is a premier full-service CRO with international capabilities serving the global pharmaceutical and biotechnology industry and is an industry leader in CNS clinical research. SCIREX’s services include clinical trial management, drug development planning, protocol design, submission services, regulatory affairs consulting, investigator and patient recruitment, data management, statistical analysis, medical writing and offers an array of technology solutions. SCIREX brings experience from more than 1,000 clinical studies involving well over 135,000 patients in most major therapeutic areas, with specific expertise in pain and inflammation, and neurological and psychiatric disorders. SCIREX is a wholly-owned subsidiary of Omnicom Group, Inc. (NYSE: OMC) (http://www.omnicomgroup.com).

# # #

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Blythe Vito
Visit website